Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert H Kim

Showing results (81-90 of 198) with videos related to

Pageof 20
Sort By:
CNS Oncology|January 19, 2022
Prolonged response of recurrent <i>IDH</i>-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumabHelen Hwang, Jiayi Huang, Karam Khaddour, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 7, 2021
Clinical Staging to Estimate the Probability of Severe Postoperative Complications in Patients With Vestibular SchwannomaHarrison J Smith, Nedim Durakovic, Bhuvic Patel, et al.
Neurosurgery|October 17, 2018
Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess SafetyKarin Sterl, Bithika Thompson, Charles W Goss, et al.
Neurosurgical Focus|November 3, 2012
Patterns in neurosurgical adverse events: open cerebrovascular neurosurgeryJudith M Wong, John E Ziewacz, Allen L Ho, et al.
The Journal of Biological Chemistry|June 13, 2018
The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicityYanchun Pan, Ying Zhu, Wei Yang, et al.
Nature Neuroscience|May 20, 2014
Inhibition of mitochondrial protein import by mutant huntingtinHiroko Yano, Sergei V Baranov, Oxana V Baranova, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2025
Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma ProgressionMatthew Ishahak, Rowland H Han, Devi Annamalai, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Modeling glioblastoma tumor progression via CRISPR-engineered brain organoidsMatthew Ishahak, Rowland H Han, Devi Annamalai, et al.
Scientific Reports|October 9, 2021
BRAF mutations may identify a clinically distinct subset of glioblastomaSamantha N McNulty, Katherine E Schwetye, Cole Ferguson, et al.
Oncotarget|August 20, 2015
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactionsRajarshi Sengupta, Amy Barone, Jayne Marasa, et al.
Pageof 20

Showing results (81-90 of 198) with videos related to

Sort By:
Pageof 20
CNS Oncology|January 19, 2022
Prolonged response of recurrent <i>IDH</i>-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumabHelen Hwang, Jiayi Huang, Karam Khaddour, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 7, 2021
Clinical Staging to Estimate the Probability of Severe Postoperative Complications in Patients With Vestibular SchwannomaHarrison J Smith, Nedim Durakovic, Bhuvic Patel, et al.
Neurosurgery|October 17, 2018
Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess SafetyKarin Sterl, Bithika Thompson, Charles W Goss, et al.
Neurosurgical Focus|November 3, 2012
Patterns in neurosurgical adverse events: open cerebrovascular neurosurgeryJudith M Wong, John E Ziewacz, Allen L Ho, et al.
The Journal of Biological Chemistry|June 13, 2018
The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicityYanchun Pan, Ying Zhu, Wei Yang, et al.
Nature Neuroscience|May 20, 2014
Inhibition of mitochondrial protein import by mutant huntingtinHiroko Yano, Sergei V Baranov, Oxana V Baranova, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 21, 2025
Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma ProgressionMatthew Ishahak, Rowland H Han, Devi Annamalai, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Modeling glioblastoma tumor progression via CRISPR-engineered brain organoidsMatthew Ishahak, Rowland H Han, Devi Annamalai, et al.
Scientific Reports|October 9, 2021
BRAF mutations may identify a clinically distinct subset of glioblastomaSamantha N McNulty, Katherine E Schwetye, Cole Ferguson, et al.
Oncotarget|August 20, 2015
Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactionsRajarshi Sengupta, Amy Barone, Jayne Marasa, et al.
Pageof 20